» Articles » PMID: 32719072

No-reflow Phenomenon and Comparison to the Normal-flow Population Postprimary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction: Case-control Study (NORM PPCI)

Overview
Journal Open Heart
Date 2020 Jul 29
PMID 32719072
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: No-reflow (NR) phenomenon is characterised by the failure of myocardial reperfusion despite the absence of mechanical coronary obstruction. NR negatively affects patient outcomes, emphasising the importance of prediction and management. The objective was to evaluate the incidence and independent predictors of NR in patients presenting with ST-elevation myocardial infarction (STEMI).

Methods: This was a single-centre prospective case-control study. Cases were subjects who suffered NR, and the control comparators were those who did not. Clinical outcomes were documented. Salient variables relating to the patients and their presentation, history and angiographical findings were compared using one-way analysis of variance or χ test. Multiple regression determined the independent predictors, and a risk score was established based on the β coefficient.

Results: Of 173 consecutive patients, 24 (13.9%) suffered from NR, with 46% occurring post stent implantation. Patients with NR had increased risk of in-hospital death (OR 7.0, 95% CI 1.3 to 36.7, p=0.022). From baseline variables available prior to percutaneous coronary intervention, the independent predictors of NR were increased lesion complexity, admission systolic hypertension, weight of <78 kg and history of hypertension. Continuous data were transformed into best-fit binary variables, and a risk score was defined. Significant difference was demonstrated between the risk score of patients with NR (4.1±1) compared with controls (2.6±1) (p<0.001), and the risk score was considered a good test (area under the curve=0.823). A score of ≥4 had 75% sensitivity and 76.5% specificity.

Conclusion: Patients with NR have a higher rate of mortality following STEMI. Predictors of NR include lesion complexity, systolic hypertension and low weight. Further validation of this risk model is required.

Citing Articles

Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models.

Ebrahimi R, Rahmani M, Fallahtafti P, Ghaseminejad-Raeini A, Azarboo A, Jalali A Ther Adv Cardiovasc Dis. 2024; 18:17539447241290438.

PMID: 39470690 PMC: 11618966. DOI: 10.1177/17539447241290438.


Incorporating Inflammation Biomarker-Driven Multivariate Predictive Model for Coronary Microcirculatory Dysfunction in Acute Myocardial Infarction Following Emergency Percutaneous Coronary Intervention.

Yao Z, Ding B, Wang J, Qian S, Song X, Li Y Clin Cardiol. 2024; 47(10):e70032.

PMID: 39429096 PMC: 11491760. DOI: 10.1002/clc.70032.


The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data.

Ryabov V, Vyshlov E, Maslov L, Naryzhnaya N, Mukhomedzyanov A, Boshchenko A Rev Cardiovasc Med. 2024; 25(3):105.

PMID: 39076959 PMC: 11263840. DOI: 10.31083/j.rcm2503105.


The role and mechanisms of microvascular damage in the ischemic myocardium.

Zhao B, Ruze A, Zhao L, Li Q, Tang J, Xiefukaiti N Cell Mol Life Sci. 2023; 80(11):341.

PMID: 37898977 PMC: 11073328. DOI: 10.1007/s00018-023-04998-z.


A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena.

Maslov L, Naryzhnaya N, Popov S, Mukhomedzyanov A, Derkachev I, Kurbatov B J Biomed Res. 2023; 37(4):281-302.

PMID: 37503711 PMC: 10387746. DOI: 10.7555/JBR.37.20230021.


References
1.
Gurbel P, Bliden K, Butler K, Antonino M, Wei C, Teng R . Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. Circulation. 2010; 121(10):1188-99. DOI: 10.1161/CIRCULATIONAHA.109.919456. View

2.
Harrison R, Aggarwal A, Ou F, Klein L, Rumsfeld J, Roe M . Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2012; 111(2):178-84. DOI: 10.1016/j.amjcard.2012.09.015. View

3.
Ramjane K, Han L, Jin C . The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol. 2009; 13(3):121-8. PMC: 2586408. View

4.
Wang C, Chen Y, Yang X, Wang L, Wang H, Sun Z . A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting. Scand Cardiovasc J. 2011; 45(2):98-104. DOI: 10.3109/14017431.2011.558209. View

5.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View